{"id":765822,"date":"2023-06-25T13:06:22","date_gmt":"2023-06-25T17:06:22","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/edelson-lechtzin-llp-is-investigating-securities-fraud-claims-on-behalf-of-tango-therapeutics-inc-nasdaq-tngx-shareholders-who-held-bctg-acquisition-corp-nasdaq-bctg-shares-prior-to-the-merge\/"},"modified":"2023-06-25T13:06:22","modified_gmt":"2023-06-25T17:06:22","slug":"edelson-lechtzin-llp-is-investigating-securities-fraud-claims-on-behalf-of-tango-therapeutics-inc-nasdaq-tngx-shareholders-who-held-bctg-acquisition-corp-nasdaq-bctg-shares-prior-to-the-merge","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/edelson-lechtzin-llp-is-investigating-securities-fraud-claims-on-behalf-of-tango-therapeutics-inc-nasdaq-tngx-shareholders-who-held-bctg-acquisition-corp-nasdaq-bctg-shares-prior-to-the-merge\/","title":{"rendered":"Edelson Lechtzin LLP is Investigating Securities Fraud Claims on Behalf of Tango Therapeutics, Inc. (NASDAQ: TNGX) Shareholders Who Held BCTG Acquisition Corp. (Nasdaq: BCTG) Shares Prior to the Merger"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">NEWTOWN, Pa., June  25, 2023  (GLOBE NEWSWIRE) &#8212; The law firm of Edelson Lechtzin LLP is investigating securities fraud and breach of fiduciary duty claims on behalf of shareholders of BCTG Acquisition Corp. (\u201cBCTG\u201d) (Nasdaq: BCTG), a special purpose acquisition company (\u201cSPAC\u201d), who acquired BCTG shares before the closing of its business combination with Tango Therapeutics, Inc. (\u201cTango Therapeutics\u201d) (Nasdaq: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=nIxesHCdWf7k_4iniHZ3X4mfoJv9evCU5AQxGqhwQ9sImxqRX2_S3iRH8WNha16E5MSeWBMuLcrTj5rUcf5yGoZomJiv5nqgDk9IU0XdWLvgx8Htg_5SVJdQrQb93LPG\" rel=\"nofollow noopener\" target=\"_blank\">TNGX<\/a>), on or before August 9, 2021.<\/p>\n<p align=\"left\">Tango Therapeutics is a biotechnology company dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. Tango Therapeutics is a Delaware corporation that maintains its principal executive offices in Boston, Massachusetts. The business combination of BCTG and Tango Therapeutics was approved by shareholders of BCTG on August 9, 2021. Tango Therapeutics common stock began trading on the NASDAQ under its new ticker symbol, \u201cTNGX,\u201d on or about August 10, 2021.<\/p>\n<p align=\"left\">BCTG investors may have claims based on alleged false and misleading statements and\/or material omissions contained in the documents used to solicit shareholder approval for the business combination between BCTG and Tango Therapeutics. Please contact Edelson Lechtzin LLP at 1-844-696-7492 to discuss your investment losses, or by e-mail at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=5B2y3x6CSqcsjBsSIAaWLX-PWTx8ltZKhkzkXCgFVKKC6Sr58u8_B2J_PeLZgzle5gRypQ-PjCxwrfSvMy-C8PBBqtBoRmZV0KxMJfv823YmZ-pueCsQg9cQNCw_25Od\" rel=\"nofollow noopener\" target=\"_blank\">elechtzin@edelson-law.com<\/a> or <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=jPP4hQtVMFI7XK490tSzHStauMLp4R_2BuM75yC81g1ifyTytEZcF16dI3U75DMW2zwWFlonPwqmtvWzcXr7S1K9mXcZjUhxb3WrPUKeD5Y=\" rel=\"nofollow noopener\" target=\"_blank\">medelson@edelson-law.com<\/a>, or you can submit your information online <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=iEubxb8tPCh3iGWX60Zk87_nZ-II-s6Qqd6H803FlKJHZpsan2h1kutbOnr8fTRJ-87gEMAthn47mS6aUfMDVA==\" rel=\"nofollow noopener\" target=\"_blank\">HERE<\/a>.<\/p>\n<p>\n        <u>For more information, please contact:<\/u>\n      <\/p>\n<p>Marc H. Edelson, Esq.<br \/>Eric Lechtzin, Esq.<br \/>EDELSON LECHTZIN LLP<br \/>411 S. State Street, Suite N-300<br \/>Newtown, PA 18940<br \/>Phone: 844-696-7492 or 215-867-2399 ext. 1<br \/>Email: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=5B2y3x6CSqcsjBsSIAaWLX-PWTx8ltZKhkzkXCgFVKI9b-YOh6UvkBT6zBhkKVkBzo-5LmB2jEy5qu-Z50Xa2EnZrn4Ao277dnz4cmwrdtmz4vYptrLzBDy4jEm3nUu6\" rel=\"nofollow noopener\" target=\"_blank\">elechtzin@edelson-law.com<\/a> or <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=jPP4hQtVMFI7XK490tSzHStauMLp4R_2BuM75yC81g1_I6HwA7q_4aZHHEr8ZUwQZztc7MWurjifbNeHIoKEYrX38M6eftn5JaxPBaL90Ow=\" rel=\"nofollow noopener\" target=\"_blank\">medelson@edelson-law.com<\/a><br \/>Web: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=bSTw1eyH8G6763M1wlqH5YFtgIQ2Z0ZbGCayoalJxwOAQjyBWFXSJ5IsW0YVnwdifZ-3znyUibQnZXqsgVFmGpcCS-NZnKzNTh5NnVa1Uns=\" rel=\"nofollow noopener\" target=\"_blank\">www.edelson-law.com<\/a>\u00a0\u00a0<\/p>\n<p>\n        <u>About Edelson Lechtzin LLP<\/u>\n      <\/p>\n<p>\n        <strong>Edelson Lechtzin LLP<\/strong> is a national class action law firm with offices in Pennsylvania and California. In addition to cases involving securities and investment fraud, our lawyers focus on class and collective litigation in cases alleging violations of the federal antitrust laws, employee benefit plans under ERISA, wage theft and unpaid overtime, consumer fraud, and dangerous and defective drugs and medical devices.<\/p>\n<p>This press release may be considered Attorney Advertising in some jurisdictions. No class has been certified in this case, so you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. Your ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.<\/p>\n<p \/>\n      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg2NDAxOSM1NjYzNTA0IzIyNTE3NTE=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/MjNlNmJjNDYtYTVjYS00NDNhLWIyNmItODU0YmQ3YjY3NGJhLTEyNjMzMDQ=\/tiny\/Edelson-Lechtzin-LLP.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>NEWTOWN, Pa., June 25, 2023 (GLOBE NEWSWIRE) &#8212; The law firm of Edelson Lechtzin LLP is investigating securities fraud and breach of fiduciary duty claims on behalf of shareholders of BCTG Acquisition Corp. (\u201cBCTG\u201d) (Nasdaq: BCTG), a special purpose acquisition company (\u201cSPAC\u201d), who acquired BCTG shares before the closing of its business combination with Tango Therapeutics, Inc. (\u201cTango Therapeutics\u201d) (Nasdaq: TNGX), on or before August 9, 2021. Tango Therapeutics is a biotechnology company dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. Tango Therapeutics is a Delaware corporation that maintains its principal executive offices in Boston, Massachusetts. The business combination of BCTG and Tango Therapeutics was approved by shareholders of &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/edelson-lechtzin-llp-is-investigating-securities-fraud-claims-on-behalf-of-tango-therapeutics-inc-nasdaq-tngx-shareholders-who-held-bctg-acquisition-corp-nasdaq-bctg-shares-prior-to-the-merge\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Edelson Lechtzin LLP is Investigating Securities Fraud Claims on Behalf of Tango Therapeutics, Inc. (NASDAQ: TNGX) Shareholders Who Held BCTG Acquisition Corp. (Nasdaq: BCTG) Shares Prior to the Merger&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-765822","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Edelson Lechtzin LLP is Investigating Securities Fraud Claims on Behalf of Tango Therapeutics, Inc. (NASDAQ: TNGX) Shareholders Who Held BCTG Acquisition Corp. (Nasdaq: BCTG) Shares Prior to the Merger - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/edelson-lechtzin-llp-is-investigating-securities-fraud-claims-on-behalf-of-tango-therapeutics-inc-nasdaq-tngx-shareholders-who-held-bctg-acquisition-corp-nasdaq-bctg-shares-prior-to-the-merge\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Edelson Lechtzin LLP is Investigating Securities Fraud Claims on Behalf of Tango Therapeutics, Inc. (NASDAQ: TNGX) Shareholders Who Held BCTG Acquisition Corp. (Nasdaq: BCTG) Shares Prior to the Merger - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"NEWTOWN, Pa., June 25, 2023 (GLOBE NEWSWIRE) &#8212; The law firm of Edelson Lechtzin LLP is investigating securities fraud and breach of fiduciary duty claims on behalf of shareholders of BCTG Acquisition Corp. (\u201cBCTG\u201d) (Nasdaq: BCTG), a special purpose acquisition company (\u201cSPAC\u201d), who acquired BCTG shares before the closing of its business combination with Tango Therapeutics, Inc. (\u201cTango Therapeutics\u201d) (Nasdaq: TNGX), on or before August 9, 2021. Tango Therapeutics is a biotechnology company dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. Tango Therapeutics is a Delaware corporation that maintains its principal executive offices in Boston, Massachusetts. The business combination of BCTG and Tango Therapeutics was approved by shareholders of &hellip; Continue reading &quot;Edelson Lechtzin LLP is Investigating Securities Fraud Claims on Behalf of Tango Therapeutics, Inc. (NASDAQ: TNGX) Shareholders Who Held BCTG Acquisition Corp. (Nasdaq: BCTG) Shares Prior to the Merger&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/edelson-lechtzin-llp-is-investigating-securities-fraud-claims-on-behalf-of-tango-therapeutics-inc-nasdaq-tngx-shareholders-who-held-bctg-acquisition-corp-nasdaq-bctg-shares-prior-to-the-merge\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-06-25T17:06:22+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg2NDAxOSM1NjYzNTA0IzIyNTE3NTE=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/edelson-lechtzin-llp-is-investigating-securities-fraud-claims-on-behalf-of-tango-therapeutics-inc-nasdaq-tngx-shareholders-who-held-bctg-acquisition-corp-nasdaq-bctg-shares-prior-to-the-merge\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/edelson-lechtzin-llp-is-investigating-securities-fraud-claims-on-behalf-of-tango-therapeutics-inc-nasdaq-tngx-shareholders-who-held-bctg-acquisition-corp-nasdaq-bctg-shares-prior-to-the-merge\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Edelson Lechtzin LLP is Investigating Securities Fraud Claims on Behalf of Tango Therapeutics, Inc. (NASDAQ: TNGX) Shareholders Who Held BCTG Acquisition Corp. (Nasdaq: BCTG) Shares Prior to the Merger\",\"datePublished\":\"2023-06-25T17:06:22+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/edelson-lechtzin-llp-is-investigating-securities-fraud-claims-on-behalf-of-tango-therapeutics-inc-nasdaq-tngx-shareholders-who-held-bctg-acquisition-corp-nasdaq-bctg-shares-prior-to-the-merge\\\/\"},\"wordCount\":409,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/edelson-lechtzin-llp-is-investigating-securities-fraud-claims-on-behalf-of-tango-therapeutics-inc-nasdaq-tngx-shareholders-who-held-bctg-acquisition-corp-nasdaq-bctg-shares-prior-to-the-merge\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODg2NDAxOSM1NjYzNTA0IzIyNTE3NTE=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/edelson-lechtzin-llp-is-investigating-securities-fraud-claims-on-behalf-of-tango-therapeutics-inc-nasdaq-tngx-shareholders-who-held-bctg-acquisition-corp-nasdaq-bctg-shares-prior-to-the-merge\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/edelson-lechtzin-llp-is-investigating-securities-fraud-claims-on-behalf-of-tango-therapeutics-inc-nasdaq-tngx-shareholders-who-held-bctg-acquisition-corp-nasdaq-bctg-shares-prior-to-the-merge\\\/\",\"name\":\"Edelson Lechtzin LLP is Investigating Securities Fraud Claims on Behalf of Tango Therapeutics, Inc. (NASDAQ: TNGX) Shareholders Who Held BCTG Acquisition Corp. (Nasdaq: BCTG) Shares Prior to the Merger - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/edelson-lechtzin-llp-is-investigating-securities-fraud-claims-on-behalf-of-tango-therapeutics-inc-nasdaq-tngx-shareholders-who-held-bctg-acquisition-corp-nasdaq-bctg-shares-prior-to-the-merge\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/edelson-lechtzin-llp-is-investigating-securities-fraud-claims-on-behalf-of-tango-therapeutics-inc-nasdaq-tngx-shareholders-who-held-bctg-acquisition-corp-nasdaq-bctg-shares-prior-to-the-merge\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODg2NDAxOSM1NjYzNTA0IzIyNTE3NTE=\",\"datePublished\":\"2023-06-25T17:06:22+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/edelson-lechtzin-llp-is-investigating-securities-fraud-claims-on-behalf-of-tango-therapeutics-inc-nasdaq-tngx-shareholders-who-held-bctg-acquisition-corp-nasdaq-bctg-shares-prior-to-the-merge\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/edelson-lechtzin-llp-is-investigating-securities-fraud-claims-on-behalf-of-tango-therapeutics-inc-nasdaq-tngx-shareholders-who-held-bctg-acquisition-corp-nasdaq-bctg-shares-prior-to-the-merge\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/edelson-lechtzin-llp-is-investigating-securities-fraud-claims-on-behalf-of-tango-therapeutics-inc-nasdaq-tngx-shareholders-who-held-bctg-acquisition-corp-nasdaq-bctg-shares-prior-to-the-merge\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODg2NDAxOSM1NjYzNTA0IzIyNTE3NTE=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODg2NDAxOSM1NjYzNTA0IzIyNTE3NTE=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/edelson-lechtzin-llp-is-investigating-securities-fraud-claims-on-behalf-of-tango-therapeutics-inc-nasdaq-tngx-shareholders-who-held-bctg-acquisition-corp-nasdaq-bctg-shares-prior-to-the-merge\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Edelson Lechtzin LLP is Investigating Securities Fraud Claims on Behalf of Tango Therapeutics, Inc. (NASDAQ: TNGX) Shareholders Who Held BCTG Acquisition Corp. (Nasdaq: BCTG) Shares Prior to the Merger\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Edelson Lechtzin LLP is Investigating Securities Fraud Claims on Behalf of Tango Therapeutics, Inc. (NASDAQ: TNGX) Shareholders Who Held BCTG Acquisition Corp. (Nasdaq: BCTG) Shares Prior to the Merger - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/edelson-lechtzin-llp-is-investigating-securities-fraud-claims-on-behalf-of-tango-therapeutics-inc-nasdaq-tngx-shareholders-who-held-bctg-acquisition-corp-nasdaq-bctg-shares-prior-to-the-merge\/","og_locale":"en_US","og_type":"article","og_title":"Edelson Lechtzin LLP is Investigating Securities Fraud Claims on Behalf of Tango Therapeutics, Inc. (NASDAQ: TNGX) Shareholders Who Held BCTG Acquisition Corp. (Nasdaq: BCTG) Shares Prior to the Merger - Market Newsdesk","og_description":"NEWTOWN, Pa., June 25, 2023 (GLOBE NEWSWIRE) &#8212; The law firm of Edelson Lechtzin LLP is investigating securities fraud and breach of fiduciary duty claims on behalf of shareholders of BCTG Acquisition Corp. (\u201cBCTG\u201d) (Nasdaq: BCTG), a special purpose acquisition company (\u201cSPAC\u201d), who acquired BCTG shares before the closing of its business combination with Tango Therapeutics, Inc. (\u201cTango Therapeutics\u201d) (Nasdaq: TNGX), on or before August 9, 2021. Tango Therapeutics is a biotechnology company dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. Tango Therapeutics is a Delaware corporation that maintains its principal executive offices in Boston, Massachusetts. The business combination of BCTG and Tango Therapeutics was approved by shareholders of &hellip; Continue reading \"Edelson Lechtzin LLP is Investigating Securities Fraud Claims on Behalf of Tango Therapeutics, Inc. (NASDAQ: TNGX) Shareholders Who Held BCTG Acquisition Corp. (Nasdaq: BCTG) Shares Prior to the Merger\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/edelson-lechtzin-llp-is-investigating-securities-fraud-claims-on-behalf-of-tango-therapeutics-inc-nasdaq-tngx-shareholders-who-held-bctg-acquisition-corp-nasdaq-bctg-shares-prior-to-the-merge\/","og_site_name":"Market Newsdesk","article_published_time":"2023-06-25T17:06:22+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg2NDAxOSM1NjYzNTA0IzIyNTE3NTE=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/edelson-lechtzin-llp-is-investigating-securities-fraud-claims-on-behalf-of-tango-therapeutics-inc-nasdaq-tngx-shareholders-who-held-bctg-acquisition-corp-nasdaq-bctg-shares-prior-to-the-merge\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/edelson-lechtzin-llp-is-investigating-securities-fraud-claims-on-behalf-of-tango-therapeutics-inc-nasdaq-tngx-shareholders-who-held-bctg-acquisition-corp-nasdaq-bctg-shares-prior-to-the-merge\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Edelson Lechtzin LLP is Investigating Securities Fraud Claims on Behalf of Tango Therapeutics, Inc. (NASDAQ: TNGX) Shareholders Who Held BCTG Acquisition Corp. (Nasdaq: BCTG) Shares Prior to the Merger","datePublished":"2023-06-25T17:06:22+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/edelson-lechtzin-llp-is-investigating-securities-fraud-claims-on-behalf-of-tango-therapeutics-inc-nasdaq-tngx-shareholders-who-held-bctg-acquisition-corp-nasdaq-bctg-shares-prior-to-the-merge\/"},"wordCount":409,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/edelson-lechtzin-llp-is-investigating-securities-fraud-claims-on-behalf-of-tango-therapeutics-inc-nasdaq-tngx-shareholders-who-held-bctg-acquisition-corp-nasdaq-bctg-shares-prior-to-the-merge\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg2NDAxOSM1NjYzNTA0IzIyNTE3NTE=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/edelson-lechtzin-llp-is-investigating-securities-fraud-claims-on-behalf-of-tango-therapeutics-inc-nasdaq-tngx-shareholders-who-held-bctg-acquisition-corp-nasdaq-bctg-shares-prior-to-the-merge\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/edelson-lechtzin-llp-is-investigating-securities-fraud-claims-on-behalf-of-tango-therapeutics-inc-nasdaq-tngx-shareholders-who-held-bctg-acquisition-corp-nasdaq-bctg-shares-prior-to-the-merge\/","name":"Edelson Lechtzin LLP is Investigating Securities Fraud Claims on Behalf of Tango Therapeutics, Inc. (NASDAQ: TNGX) Shareholders Who Held BCTG Acquisition Corp. (Nasdaq: BCTG) Shares Prior to the Merger - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/edelson-lechtzin-llp-is-investigating-securities-fraud-claims-on-behalf-of-tango-therapeutics-inc-nasdaq-tngx-shareholders-who-held-bctg-acquisition-corp-nasdaq-bctg-shares-prior-to-the-merge\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/edelson-lechtzin-llp-is-investigating-securities-fraud-claims-on-behalf-of-tango-therapeutics-inc-nasdaq-tngx-shareholders-who-held-bctg-acquisition-corp-nasdaq-bctg-shares-prior-to-the-merge\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg2NDAxOSM1NjYzNTA0IzIyNTE3NTE=","datePublished":"2023-06-25T17:06:22+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/edelson-lechtzin-llp-is-investigating-securities-fraud-claims-on-behalf-of-tango-therapeutics-inc-nasdaq-tngx-shareholders-who-held-bctg-acquisition-corp-nasdaq-bctg-shares-prior-to-the-merge\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/edelson-lechtzin-llp-is-investigating-securities-fraud-claims-on-behalf-of-tango-therapeutics-inc-nasdaq-tngx-shareholders-who-held-bctg-acquisition-corp-nasdaq-bctg-shares-prior-to-the-merge\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/edelson-lechtzin-llp-is-investigating-securities-fraud-claims-on-behalf-of-tango-therapeutics-inc-nasdaq-tngx-shareholders-who-held-bctg-acquisition-corp-nasdaq-bctg-shares-prior-to-the-merge\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg2NDAxOSM1NjYzNTA0IzIyNTE3NTE=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg2NDAxOSM1NjYzNTA0IzIyNTE3NTE="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/edelson-lechtzin-llp-is-investigating-securities-fraud-claims-on-behalf-of-tango-therapeutics-inc-nasdaq-tngx-shareholders-who-held-bctg-acquisition-corp-nasdaq-bctg-shares-prior-to-the-merge\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Edelson Lechtzin LLP is Investigating Securities Fraud Claims on Behalf of Tango Therapeutics, Inc. (NASDAQ: TNGX) Shareholders Who Held BCTG Acquisition Corp. (Nasdaq: BCTG) Shares Prior to the Merger"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/765822","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=765822"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/765822\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=765822"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=765822"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=765822"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}